RYR1 and centronuclear myopathy: Indeed, the identification of mutations in RYR1 leading to CNM (Jungbluth et al., 2007; Wilmshurst et al., 2010) further supports the notion that triad dysfunction, Ca2+ dysregulation and EC coupling are key pathogenic drivers of CNM (Dowling et al., 2014).